Revascularization reduces mortality in patients with high risk coronary artery disease based on multi-slice CT

Original title: All-cause mortality benefit of coronary revascularization vs. medical therapy in patients without known coronary artery disease undergoing coronary computed tomographic angiography: results from CONFIRM (Coronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry) Reference: James K Min et al. European Heart Journal (2012) 33, 3088–3097 doi:10.1093/eurheartj/ehs315.

Several large studies have shown revascularization reduces mortality in stable patients with high risk CAD based on conventional angiography. The goal of this study was to determine the impact in mortality rate of revascularization vs. medical therapy of patients with coronary disease based on CT. 

This observational study included 15223 patients without known coronary condition undergoing multi-slice coronary CT (≥ 64 detectors), divided in high risk (two-vessel CAD with proximal left anterior descending artery involvement, three-vessel CAD, and left main CAD) and low risk CAD. To identify revascularization or medical therapy predictors, they created a score developed by logistic regression. The primary end point was all-cause mortality. 

Revascularization rate was different depending on severity, from 3.8% for non-high-risk CAD to 51.2% high-risk CAD (p<0.01). 82.8% of revascularized patients were treated with angioplasty. Follow up median was 2.1 years (interquartile range 1.4-3.3 years).

After adjusting confounding factors, a reduction in all-cause mortality rates was observed in revascularized patients with high risk CAD, compared to those that received medical therapy (2.28% vs. 5.34% respectively p=0.0075). In low risk CAD patients no differences were observed (2.06% vs. 0.97% p=0.138).

Conclusion 

In patients with no previous history of CAD classified as high risk CAD patients based on multi-slice CT, revascularization reduced all-cause mortality rate.

Editorial Comment:

As an observation study, all outcomes produce more hypotheses that require further randomized studies. On the other hand, CTs are competing with functional studies as screening techniques and this study provides us with the tools to decide when to proceed with coronary angiography and revascularization.

SOLACI.ORG

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...